Infinity Pharma Stock Price (NASDAQ:INFI)

Add to My Stocks
$2.05 $0.33 (19.19%) INFI stock closing price Jun 22, 2018 (Closing)
Prev Close* : $1.72
Market Cap:
Day Low: $1.77
52 Week Low: $0.93
Open: $1.8
Volume: -
Day High: $2.08
52 Week High: $3.75

Latest Stock Market News

Latest Articles

Infinity Pharma News - From Partners

INFI Stockcharts

View INFI PE ratio, PS ratio stocks charts and compare with peers.
INFI Chart
Note: Compare Infinity Pharma stock price history with the index and industry peers.

Infinity Pharma Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Infinity Pharma Returns

(return on equity)

Infinity Pharma Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

INFI Industry Peers

Company Price Change (%)
Biolinerx (BLRX)0.920.01 (1.1%)
Cytodyn (CYDY)0.450.02 (4.26%)
Seattle Genetics (SGEN)66.850.24 (0.36%)
Bristol-myers Squibb (BMY)55.141.2 (2.22%)
Johnson & Johnson (JNJ)122.841.39 (1.14%)
Arqule (ARQL)4.760.07 (1.49%)
Gilead Sciences (GILD)71.070.45 (0.63%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
CASI Pharma (CASI)6.280.57 (9.98%)
Tesaro Inc (TSRO)49.623.87 (8.46%)
ACER THERAPEUTS (ACER)20.681.43 (7.43%)
Catalyst Pharma (CPRX)3.390.21 (6.6%)
Nature's Sunshine Products (NATR)9.250.45 (5.11%)
BioSpecifics Technologies (BSTC)43.912.01 (4.8%)
ChemoCentryx (CCXI)12.030.53 (4.61%)
Top gainers from Medical-Drugs industry
* As of Jun 22, 2018
CompanyPriceChange (%)
AVADEL PHARMA (AVDL)6.270.44 (6.56%)
Zogenix (ZGNX)44.72.85 (5.99%)
Nektar Therapeutics (NKTR)52.853.01 (5.39%)
MELINTA THERAPT (MLNT)7.10.35 (4.7%)
Adamis Pharma (ADMP)3.450.13 (3.64%)
BioCryst Pharma (BCRX)5.590.18 (3.12%)
Synergy Pharma (SGYP)1.890.06 (3.08%)
Top losers from Medical-Drugs industry
* As of Jun 22, 2018

Infinity Pharmaceuticals Inc. Stock News - Partner Headlines

Value Investing in BioPharma   on Nov 18, 2015

Infinity Pharma Financial Statements

income statement20172016201520142013
Net Sales or Revenues6M18.72M109.06M164.99M-
Net Income-41.83M-30.1M-128.37M-17.41M-126.78M
Total Operating Expense42.44M49.62M236.16M172.91M127.67M
View Infinity Pharma income statement
balance sheet20172016201520142013
Total Assets59.35M125.65M288.82M369.14M230.71M
Total Liabilities11.62M43.2M190.26M159.67M29.43M
Shareholders Equity47.73M82.45M98.55M209.47M201.27M
View Infinity Pharma balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-10.68M-29.22M26.97M109.57M-3.71M
Net Cash from (used by) Operating Activities-36.71M-154.35M-83.65M117.71M-113.9M
Increase (Decrease) in Prop Plant And Equipment-1.47M-6.42M-1.36M-1.75M
View Infinity Pharma cash flow statement

Infinity Pharma Stock Message Board

An investor needs to spend $2.05 to buy INFI stock, as the closing Infinity Pharma stock price is $2.05. Stock price or share price can be used to find the total market value of a company. Infinity Pharma market cap stands at $96.44M as of Jun 22, 2018. Infinity Pharma valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

For recognizing and analyzing the real performance of Infinity Pharma stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. 2,945,019 INFI shares were traded yesterday, and Infinity Pharma stock chart shows that the INFI stock quote hit a day high of $2.08 and day low of $1.77. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Infinity Pharma stock dividend was 0.00 during the last quarter. One can observe stock price trends and check for volatility by checking Infinity Pharma stock price history.